307 related articles for article (PubMed ID: 25856682)
1. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
Koch S; Ahn JR; Koehle MS
Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682
[TBL] [Abstract][Full Text] [Related]
2. Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists.
Koch S; MacInnis MJ; Sporer BC; Rupert JL; Koehle MS
Br J Sports Med; 2015 Jan; 49(1):51-5. PubMed ID: 24100289
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction.
Koch S; Karacabeyli D; Galts C; MacInnis MJ; Sporer BC; Koehle MS
J Sci Med Sport; 2015 Sep; 18(5):607-12. PubMed ID: 25156879
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic Effects of Inhaled Salbutamol on 10-km Time Trial Performance in Competitive Male and Female Cyclists.
Koch S; MacInnis MJ; Rupert JL; Sporer BC; Koehle MS
Clin J Sport Med; 2016 Mar; 26(2):145-51. PubMed ID: 25894531
[TBL] [Abstract][Full Text] [Related]
5. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
van Baak MA; de Hon OM; Hartgens F; Kuipers H
Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
[TBL] [Abstract][Full Text] [Related]
6. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
7. Self-reported Symptoms after Induced and Inhibited Bronchoconstriction in Athletes.
Simpson AJ; Romer LM; Kippelen P
Med Sci Sports Exerc; 2015 Oct; 47(10):2005-13. PubMed ID: 25710876
[TBL] [Abstract][Full Text] [Related]
8. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
[TBL] [Abstract][Full Text] [Related]
9. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
10. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
11. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
12. Dose response of inhaled salbutamol on exercise performance and urine concentrations.
Sporer BC; Sheel AW; McKenzie DC
Med Sci Sports Exerc; 2008 Jan; 40(1):149-57. PubMed ID: 18091010
[TBL] [Abstract][Full Text] [Related]
13. Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.
Simpson AJ; Tufvesson E; Anderson SD; Romer LM; Bjermer L; Kippelen P
J Appl Physiol (1985); 2013 Nov; 115(10):1450-6. PubMed ID: 24030662
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute salbutamol inhalation on quadriceps force and fatigability.
Decorte N; Verges S; Flore P; Guinot M; Wuyam B
Med Sci Sports Exerc; 2008 Jul; 40(7):1220-7. PubMed ID: 18580400
[TBL] [Abstract][Full Text] [Related]
15. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
[TBL] [Abstract][Full Text] [Related]
16. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.
Heir T; Stemshaug H
Scand J Med Sci Sports; 1995 Aug; 5(4):231-6. PubMed ID: 7552768
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
18. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
[TBL] [Abstract][Full Text] [Related]
19. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
Lötvall J; Ankerst J
Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
[TBL] [Abstract][Full Text] [Related]
20. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
